Cargando…

Cellular Immune Responses to Nine Mycobacterium tuberculosis Vaccine Candidates following Intranasal Vaccination

BACKGROUND: The identification of Mycobacterium tuberculosis vaccines that elicit a protective immune response in the lungs is important for the development of an effective vaccine against tuberculosis. METHODS AND PRINCIPAL FINDINGS: In this study, a comparison of intranasal (i.n.) and subcutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sable, Suraj B., Cheruvu, Mani, Nandakumar, Subhadra, Sharma, Sunita, Bandyopadhyay, Kakali, Kellar, Kathryn L., Posey, James E., Plikaytis, Bonnie B., Amara, Rama Rao, Shinnick, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143185/ https://www.ncbi.nlm.nih.gov/pubmed/21799939 http://dx.doi.org/10.1371/journal.pone.0022718

Ejemplares similares

Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis
por: Nandakumar, Subhadra, et al.
Publicado: (2016)

Attrition of T-Cell Functions and Simultaneous Upregulation of Inhibitory Markers Correspond with the Waning of BCG-Induced Protection against Tuberculosis in Mice
por: Nandakumar, Subhadra, et al.
Publicado: (2014)

O-mannosylation of the Mycobacterium tuberculosis Adhesin Apa Is Crucial for T Cell Antigenicity during Infection but Is Expendable for Protection
por: Nandakumar, Subhadra, et al.
Publicado: (2013)

Strategies for intranasal delivery of vaccines
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Design of Polymeric Nanocapsules for Intranasal Vaccination against Mycobacterium Tuberculosis: Influence of the Polymeric Shell and Antigen Positioning
por: Diego-González, Lara, et al.
Publicado: (2020)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

Intranasal COVID-19 vaccine: a modern vaccination approach
por: Shahnoor, Syeda, et al.
Publicado: (2023)

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting
por: Roces, Carla B., et al.
Publicado: (2019)

DNA/MVA Vaccines for HIV/AIDS
por: Iyer, Smita S., et al.
Publicado: (2014)

Advantages of Intranasal Vaccination and Considerations on Device Selection
por: Birkhoff, M., et al.
Publicado: (2009)

Note upon Nine Cases of Accidental Vaccination
por: Felkin, R. W.
Publicado: (1891)

Note upon Nine Cases of Accidental Vaccination
por: Felkin, R. W.
Publicado: (1891)

Analysis of the Vaccine Potential of Plasmid DNA Encoding Nine Mycolactone Polyketide Synthase Domains in Mycobacterium ulcerans Infected Mice
por: Roupie, Virginie, et al.
Publicado: (2014)

Intranasal COVID-19 vaccines: Is it a boon or bane?
por: Choudhary, Om Prakash, et al.
Publicado: (2021)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Influenza Vaccination in Adults with Chronic Obstructive Pulmonary Disease: The Impact of a Diagnostic Breathing Test on Vaccination Rates
por: Mowls, Dana S., et al.
Publicado: (2013)

Intranasal vaccination with Listeria ivanovii as vector of Mycobacterium tuberculosis antigens promotes specific lung-localized cellular and humoral immune responses
por: Jiang, Ming-juan, et al.
Publicado: (2020)

Correction: Influenza Vaccination in Adults with Chronic Obstructive Pulmonary Disease: The Impact of a Diagnostic Breathing Test on Vaccination Rates
por: Mowls, Dana S., et al.
Publicado: (2013)

Flu vaccine associated with nine deaths in Japan this year
Publicado: (2013)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
por: Boiron, L., et al.
Publicado: (2016)

Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
por: Gizurarson, Sveinbjörn
Publicado: (2012)

Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
por: Voß, Franziska, et al.
Publicado: (2018)

Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
por: Biswas, Mrityunjoy, et al.
Publicado: (2020)

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier
por: Gao, Xiaoyi, et al.
Publicado: (2021)

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
por: Adashi, Eli Y., et al.
Publicado: (2022)

A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine
por: Scadding, Glenis Kathleen
Publicado: (2022)

Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
por: Duong, Van-An, et al.
Publicado: (2023)

Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008–2012
por: Cheruvu, Vinay K., et al.
Publicado: (2017)

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017)

An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2
por: Thapa, Himadri B., et al.
Publicado: (2021)

Identification of two Mycobacterium tuberculosis H37Rv ORFs involved in resistance to killing by human macrophages
por: Miller, Barbara H, et al.
Publicado: (2001)

Subunit Vaccine ESAT-6:c-di-AMP Delivered by Intranasal Route Elicits Immune Responses and Protects Against Mycobacterium tuberculosis Infection
por: Ning, Huanhuan, et al.
Publicado: (2021)

Genome-Wide Analysis of Intergenic Regions of Mycobacterium tuberculosis H37Rv Using Affymetrix GeneChips
por: Fu, Li M, et al.
Publicado: (2007)

Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine
por: Jackson, Erin M., et al.
Publicado: (2012)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
por: Dhama, Kuldeep, et al.
Publicado: (2022)

A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination
por: Sato-Kaneko, Fumi, et al.
Publicado: (2022)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hbn4not0dg7tg1el78nkccqj3n